Citadel Advisors’s Equillium EQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.5K Sell
16,400
-14,800
-47% -$35.5K ﹤0.01% 13090
2026
Q1
$62.4K Sell
31,200
-48,400
-61% -$79.6K ﹤0.01% 12308
2025
Q4
$123K Buy
+79,600
New +$97K ﹤0.01% 11474
2025
Q2
Sell
-100
Closed -$39 13194
2025
Q1
$39 Buy
+100
New +$75 ﹤0.01% 14348
2024
Q2
Sell
-200
Closed -$462 14536
2024
Q1
$462 Buy
+200
New +$348 ﹤0.01% 14326
2023
Q4
Sell
-200
Closed -$148 14513
2023
Q3
$148 Sell
200
-1,000
-83% -$802 ﹤0.01% 14151
2023
Q2
$900 Buy
+1,200
New +$794 ﹤0.01% 14024
2023
Q1
Sell
-5,900
Closed -$6.49K 14896
2022
Q4
$6.49K Sell
5,900
-32,000
-84% -$51.3K ﹤0.01% 13912
2022
Q3
$84K Buy
+37,900
New +$90.5K ﹤0.01% 11237

Other funds holding EQ

Citadel Advisors's EQ Position: Q2 2026 in Review

Citadel Advisors reduced its Equillium (EQ) stake by 37% in Q2 2026, selling an estimated $142K and leaving 99,662 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #10981.

Citadel Advisors first reported a position in EQ in Q4 2018 and has held it in 16 quarters since. The position peaked at $867K in Q4 2018. 60 funds tracked by Wall St. Rank hold EQ as of Q2 2026.

  • Citadel Advisors held 99,662 shares of Equillium worth $319K as of Q2 2026.
  • Citadel Advisors sold 59,071 Equillium shares in Q2 2026, an estimated $142K.
  • Equillium made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #10981 holding.
  • Citadel Advisors first reported a position in Equillium in Q4 2018 and has held it in 16 quarters since.
  • Citadel Advisors's Equillium position peaked at $867K in Q4 2018.
  • 60 funds tracked by Wall St. Rank held Equillium as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.